Barely Significant
← all excerpts

Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma.

Front Immunol · 2025 · PMC12041008 · PMID 40308607

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

showed a trendP < 0.001actually significant
Consistently, DIRAS3 and FOSB showed a trend of downregulation in MM patients relative to normal subjects (P < 0.001), whereas the other genes showed the opposite trend (P < 0.001) ( Figure 12 ). 4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.